FUT2 non-secretor status is associated with Type 1 diabetes susceptibility in Japanese children

Diabetic Medicine

Volumn 34, Issue 4, 2017, Pages 586-589

  Ihara, K ^a,b   Fukano, C ^a   Ayabe, T ^c   Fukami, M ^c   Ogata, T ^c,d   Kawamura, T ^e   Urakami, T ^f   Kikuchi, N ^g   Yokota, I ^h,i   Takemoto, K ^j,k   Mukai, T ^l,m   Nishii, A ⁿ   Kikuchi, T ^o,p   Mori, T ^q,r   Shimura, N ^s   Sasaki, G ^t   Kizu, R ^u   Takubo, N ^v,w   Soneda, S ^x   Fujisawa, T ^y   Takaya, R ^z   Kizaki, Z ^aa   Kanzaki, S ^ab   Hanaki, K ^ac   Matsuura, N ^ad,ae   Kasahara, Y ^af   Kosaka, K ^ag   Takahashi, T ^ah   Minamitani, K ^ai   Matsuo, S ^aj   Mochizuki, H ^ak   Kobayashi, K ^al   Koike, A ^am   Horikawa, R ^an   Teno, S ^ao   Tsubouchi, K ^ap   Mochizuki, T ^aq,ar   Igarashi, Y ^as   Amemiya, S ^o   Sugihara, S ^at   more..

^a KYUSHU UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

^f NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g YOKOHAMA CITY MINATO RED CROSS HOSPITAL   (Japan)

^h SHIKOKU MEDICAL CENTER FOR CHILDREN AND ADULTS   (Japan)

ⁱ UNIVERSITY OF TOKUSHIMA   (Japan)

^j EHIME UNIVERSITY HOSPITAL   (Japan)

^k Sumitomo Besshi Hospital   (Japan)

^l ASAHIKAWA MEDICAL COLLEGE   (Japan)

^m Asahikawa Kosei General Hospital   (Japan)

ⁿ Japan   (Japan)

^o SAITAMA MEDICAL UNIVERSITY HOSPITAL   (Japan)

^p NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^q NAGANO RED CROSS HOSPITAL   (Japan)

^r Shinshu Ueda Medical Center   (Japan)

^s DOKKYO MEDICAL UNIVERSITY   (Japan)

^t TOKYO DENTAL COLLEGE   (Japan)

^u YOKOSUKA KYOSAI HOSPITAL   (Japan)

^v KITASATO UNIVERSITY HOSPITAL   (Japan)

^w JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^x ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^y MIE NATIONAL HOSPITAL   (Japan)

^z OSAKA MEDICAL COLLEGE   (Japan)

^aa KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^ab TOTTORI UNIVERSITY   (Japan)

^ac Tottori Prefectural Kousei Hospital   (Japan)

^ad TEINE KEIJINKAI HOSPITAL   (Japan)

^ae SEITOKU UNIVERSITY   (Japan)

^af KANAZAWA UNIVERSITY   (Japan)

^ag KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^ah Takahashi Clinic   (Japan)

^ai TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^aj Matsuo Kodomo Clinic   (Japan)

^ak SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^al YAMANASHI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^am Koike Children's Clinic   (Japan)

^an NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^ao Teno Clinic   (Japan)

^ap Chuno Kosei Hospital   (Japan)

^aq OSAKA CITY GENERAL HOSPITAL   (Japan)

^ar OSAKA POLICE HOSPITAL   (Japan)

^as Igarashi Children's Clinic   (Japan)

^at TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BLOOD GROUP ABO SYSTEM; CHILD; CHILD HEALTH; CONTROLLED STUDY; FUT2 GENE; GENE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; JAPAN;

FUCOSYLTRANSFERASE; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE;

ABO BLOOD-GROUP SYSTEM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FUCOSYLTRANSFERASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN;

EID: 85006868791     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13288     Document Type: Article

References (18)

1. Stankov K, Benc D, Draskovic D. Genetic and epigenetic factors in etiology of diabetes mellitus type 1. Pediatrics 2013; 132: 1112–1122.
2. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007; 450: 887–892.
3. Todd JA. Etiology of type 1 diabetes. Immunity 2010; 32: 457–467.
4. Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Ruvoen N, Clement M et al. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 2001; 83: 565–573.
5. D'Adamo PJ, Kelly GS. Metabolic and immunologic consequences of ABH secretor and Lewis subtype status. Altern Med Rev 2001; 6: 390–405.
6. Rausch P, Rehman A, Kunzel S, Hasler R, Ott SJ, Schreiber S et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci USA 2011; 108: 19030–19035.
7. Hu D, Zhang D, Zheng S, Guo M, Lin X, Jiang Y. Association of Ulcerative Colitis with FUT2 and FUT3 Polymorphisms in Patients from Southeast China. PLoS One 2016; 11: e0146557.
8. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41: 703–707.
9. Smyth DJ, Cooper JD, Howson JM, Clarke P, Downes K, Mistry T et al. FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection. Diabetes 2011; 60: 3081–3084.
10. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000; 23: 1516–1526.
11. Sugihara S, Ogata T, Kawamura T, Urakami T, Takemoto K, Kikuchi N et al. HLA-class II and class I genotypes among Japanese children with Type 1A diabetes and their families. Pediatr Diabetes 2012; 13: 33–44.
12. Yamamura K, Ihara K, Ikeda K, Nagata H, Mizuno Y, Hara T. Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease. Int J Immunogenet 2012; 39: 119–125.
13. Koda Y, Soejima M, Liu Y, Kimura H. Molecular basis for secretor type alpha(1,2)-fucosyltransferase gene deficiency in a Japanese population: a fusion gene generated by unequal crossover responsible for the enzyme deficiency. Am J Hum Genet 1996; 59: 343–350.
14. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med 2000; 343: 141–144.
15. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003; 9: 548–553.
16. Diaz-Horta O, Baj A, Maccari G, Salvatoni A, Toniolo A. Enteroviruses and causality of type 1 diabetes: how close are we? Pediatr Diabetes 2012; 13: 92–99.
17. Hazra A, Kraft P, Selhub J, Giovannucci EL, Thomas G, Hoover RN et al. Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat Genet 2008; 40: 1160–1162.
18. Ayabe T, Fukami M, Ogata T, Kawamura T, Urakami T, Kikuchi N et al. Variants associated with autoimmune Type 1 diabetes in Japanese children: implications for age-specific effects of cis-regulatory haplotypes at 17q12-q21. Diabet Med 2016; 33: 1717–1722.